Novo is paying Gensaic up to $354 million per target in upfront fees and development and commercial milestones, plus tiered ...

And that's just in the U.S. -- obesity affected more than 1 billion people worldwide in 2022. So it's no surprise ... in the pharmaceutical world. Even if Novo Nordisk loses considerable share ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE:NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class ...

Danish asset manager Novo Holdings, which is owned by Novo Nordisk Foundation (NNF), the majority voting shareholder of ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

The VBP for insulin – which applies to supplies destined for hospitals in China – is expected to be implemented during the first half of 2022, according to Novo Nordisk. The company says it ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022. The FDA's announcement comes months after drugmaker Novo Nordisk told the agency ...

president of Novo Nordisk Inc., said in a statement Friday. GLP-1 drugs had been in shortage since 2022 due to increased demand, and a law allowed compounding pharmacies to step in to fill supply ...

A former Argentina youth international, Ríos Novo will be on his second loan spell in MLS. The 22-year-old posted two clean sheets in 16 appearances with Atlanta United during the 2022 season.